title: Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia.
abstract: BACKGROUND
  Nox-2 (also known as gp91phox), a subunit component of NADPH oxidases, generates reactive oxygen species (ROS). Nox-dependent ROS generation and nitric oxide (NO) release by microglia have been implicated in a variety of diseases in the central nervous system. Dexamethasone (Dex) has been shown to suppress the ROS production, NO release and inflammatory reaction of activated microglial cells. However, the underlying mechanisms remain unclear.
  
  
  RESULTS
  The present study showed that the increased ROS production and NO release in activated BV-2 microglial cells by LPS were associated with increased expression of Nox-2 and iNOS. Dex suppressed the upregulation of Nox-2 and iNOS, as well as the subsequent ROS production and NO synthesis in activated BV-2 cells. This inhibition caused by Dex appeared to be mediated by upregulation of MAPK phosphatase-1 (MKP-1), which antagonizes the activity of mitogen-activated protein kinases (MAPKs). Dex induced-suppression of Nox-2 and -upregulation of MKP-1 was also evident in the activated microglia from corpus callosum of postnatal rat brains. The overexpression of MKP-1 or inhibition of MAPKs (by specific inhibitors of JNK and p38 MAPKs), were found to downregulate the expression of Nox-2 and iNOS and thereby inhibit the synthesis of ROS and NO in activated BV-2 cells. Moreover, Dex was unable to suppress the LPS-induced synthesis of ROS and NO in BV-2 cells transfected with MKP-1 siRNA. On the other hand, knockdown of Nox-2 in BV-2 cells suppressed the LPS-induced ROS production and NO release.
  
  
  CONCLUSIONS
  In conclusion, it is suggested that downregulation of Nox-2 and overexpression of MKP-1 that regulate ROS and NO may form the potential therapeutic strategy for the treatment of neuroinflammation in neurodegenerative diseases.
authors: Department of Anatomy Yong Loo Lin school of Medicine National University of Singapore, 117597, Singapore.
authors: Yingqian
authors: Y
authors: Huo
authors: Parakalan
authors: P
authors: Rangarajan
authors: Eng-Ang
authors: EA
authors: Ling
authors: S Thameem
authors: ST
authors: Dheen
references: J Exp Med. 1996 Oct 1;184(4):1425-33
references: 8879214
references: FASEB J. 2001 Feb;15(2):285-7
references: 11156938
references: J Neurochem. 2006 Aug;98(4):1200-16
references: 16787408
references: J Biol Chem. 2004 Dec 24;279(52):54023-31
references: 15485842
references: Mol Cell Biol. 2005 Jun;25(11):4792-803
references: 15899879
references: J Neurosci. 2003 Aug 27;23(21):7922-30
references: 12944523
references: Neurochem Int. 2003 Jan;42(2):131-7
references: 12421593
references: Science. 1990 Sep 7;249(4973):1157-61
references: 2118682
references: Proc Natl Acad Sci U S A. 2003 May 13;100(10):6145-50
references: 12721370
references: Ann N Y Acad Sci. 2002 May;962:207-11
references: 12076976
references: Neuron. 2006 Jan 5;49(1):67-79
references: 16387640
references: Glia. 2009 Apr 15;57(6):604-21
references: 18942743
references: Am J Physiol. 1996 Nov;271(5 Pt 1):C1424-37
references: 8944624
references: Stroke. 1997 Nov;28(11):2252-8
references: 9368573
references: J Immunol. 2002 Dec 1;169(11):6408-16
references: 12444149
references: Mol Cell Biol. 2002 Nov;22(22):7802-11
references: 12391149
references: Ann N Y Acad Sci. 2005 Aug;1053:107-20
references: 16179514
references: Inflammation. 2002 Oct;26(5):215-22
references: 12238564
references: Mol Pharmacol. 2002 Sep;62(3):698-704
references: 12181447
references: Free Radic Biol Med. 1996;21(3):335-48
references: 8855444
references: J Neurosci Res. 2001 Oct 15;66(2):163-70
references: 11592111
references: Endocrinology. 2003 Feb;144(2):412-22
references: 12538600
references: Brain Res Bull. 2007 Apr 30;72(2-3):148-51
references: 17352938
references: Glia. 1993 Jan;7(1):111-8
references: 8423058
references: FEBS Lett. 1992 Sep 7;309(2):190-2
references: 1505682
references: J Endocrinol. 2003 Jul;178(1):5-12
references: 12844330
references: Cytokine. 2000 Jul;12(7):874-80
references: 10880231
references: J Biol Chem. 1986 Oct 5;261(28):13247-51
references: 3759962
references: Brain Behav Immun. 2004 Sep;18(5):407-13
references: 15265532
references: Nature. 2001 Mar 1;410(6824):37-40
references: 11242034
references: J Biol Chem. 2002 Aug 16;277(33):30010-8
references: 12011047
references: Exp Mol Med. 2006 Aug 31;38(4):333-47
references: 16953112
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Am J Physiol Heart Circ Physiol. 2004 Jun;286(6):H2442-51
references: 15148062
references: Curr Med Chem. 2007;14(11):1189-97
references: 17504139
references: J Biol Chem. 2003 Apr 11;278(15):13309-17
references: 12551918
references: EMBO J. 2001 Dec 17;20(24):7108-16
references: 11742987
references: Cancer Res. 2006 May 1;66(9):4888-94
references: 16651445
references: Exp Neurol. 2005 Jun;193(2):279-90
references: 15869932
references: IUBMB Life. 2003 Jun;55(6):307-13
references: 12938732
references: J Neuroimmunol. 1998 Dec 1;92(1-2):67-75
references: 9916881
references: Mech Ageing Dev. 2004 Oct-Nov;125(10-11):799-810
references: 15541774
references: Am J Pathol. 1996 Jul;149(1):21-8
references: 8686745
references: Eur J Neurosci. 2003 Nov;18(9):2527-37
references: 14622153
references: Glia. 2005 May;50(3):235-46
references: 15739188
references: J Immunol. 1992 Oct 15;149(8):2736-41
references: 1383325
references: J Neurochem. 2007 Aug;102(3):667-78
references: 17403137
references: J Biol Chem. 2004 Feb 13;279(7):5837-45
references: 14638694
references: Endocrinology. 2008 Apr;149(4):1654-65
references: 18187551